Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Asthma

  Free Subscription


13.05.2024

1 Acta Paediatr
1 Allergy
3 Ann Allergy Asthma Immunol
1 BMC Pediatr
1 BMJ
1 Chest
1 Clin Exp Allergy
1 Int Arch Allergy Immunol
2 J Allergy Clin Immunol
3 J Asthma
2 Pediatr Pulmonol
1 Respir Res
2 Respirology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Paediatr

  1. CSONKA P, Hamelmann E, Turkalj M, Roberts G, et al
    SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials.
    Acta Paediatr. 2024;113:1209-1220.
    PubMed         Abstract available


    Allergy

  2. RANJBAR M, Whetstone CE, Cusack RP, Al-Sajee D, et al
    Comparison of upper and lower airway expression of SARS-COV-2 receptors in allergic asthma.
    Allergy. 2024 May 10. doi: 10.1111/all.16157.
    PubMed        


    Ann Allergy Asthma Immunol

  3. KLOEPFER KM, Kennedy JL
    Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
    Ann Allergy Asthma Immunol. 2024;132:553-554.
    PubMed        

  4. KATIAL RK, Hoyte FCL
    Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
    Ann Allergy Asthma Immunol. 2024;132:551-552.
    PubMed        

  5. CHEN C, Song X, Murdock DJ, Marcus A, et al
    Association between allergic conditions and COVID-19 susceptibility and outcomes.
    Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
    PubMed         Abstract available


    BMC Pediatr

  6. TIAN C, Xiong S, Li S, Song X, et al
    Impulse oscillometry in the diagnosis of cough variant asthma in children.
    BMC Pediatr. 2024;24:296.
    PubMed         Abstract available


    BMJ

  7. IACOBUCCI G
    Montelukast: UK regulator says asthma drug needs clearer warnings of side effects.
    BMJ. 2024;385:q1048.
    PubMed        


    Chest

  8. WU WW, Wang G
    How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
    Chest. 2024;165:e157-e158.
    PubMed        


    Clin Exp Allergy

  9. HOWARD R, Fontanella S, Simpson A, Murray CS, et al
    Component-specific clusters for diagnosis and prediction of allergic airway diseases.
    Clin Exp Allergy. 2024;54:339-349.
    PubMed         Abstract available


    Int Arch Allergy Immunol

  10. XU C, Chai D, Zheng P, Qiu R, et al
    The Sensitization Differences of Pollen Allergen Components in Patients with Asthma and/or Rhinitis in Southern China.
    Int Arch Allergy Immunol. 2024 May 3:1-6. doi: 10.1159/000538403.
    PubMed         Abstract available


    J Allergy Clin Immunol

  11. SHIN YH, Kim JH, Lee SH, Lee SY, et al
    Allergic rhinitis phenotypes with distinct transcriptome profiles in children: a birth cohort.
    J Allergy Clin Immunol. 2024 Jan 17:S0091-6749(24)00032.
    PubMed         Abstract available

  12. SAKANO Y, Sakano K, Hurrell BP, Helou DG, et al
    Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity.
    J Allergy Clin Immunol. 2024;153:1406-1422.
    PubMed         Abstract available


    J Asthma

  13. KROLL H, Feinberg T, Soffer G, Reznik M, et al
    Concordance of Provider Chart Notation and Guideline-Based Classification of Asthma Severity.
    J Asthma. 2024 May 8:1-15. doi: 10.1080/02770903.2024.2353106.
    PubMed         Abstract available

  14. SALERNI C, Baccelli A, Parazzini EM, Rinaldo R, et al
    A tailored approach to refractory severe Mepolizumab-associated headache: a case study.
    J Asthma. 2024;61:649-652.
    PubMed         Abstract available

  15. SOLANKI N, Beck B, Labadia M, Smith K, et al
    The role of ACT score in mepolizumab discontinuation.
    J Asthma. 2024;61:550-560.
    PubMed         Abstract available


    Pediatr Pulmonol

  16. STEIMEL E, Bayer DK, Wright BA, Hinds DM, et al
    Little lungs, big relief: Dupilumab in a 2-year-old with severe persistent asthma.
    Pediatr Pulmonol. 2024 May 9. doi: 10.1002/ppul.27058.
    PubMed        

  17. HA EK, Jin JO, Kim JH, Shin J, et al
    Age-related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children.
    Pediatr Pulmonol. 2024 May 6. doi: 10.1002/ppul.26907.
    PubMed         Abstract available


    Respir Res

  18. AU-DOUNG PLW, Chan JCH, Kui OYH, Ho MKY, et al
    Objective monitoring tools for improved management of childhood asthma.
    Respir Res. 2024;25:194.
    PubMed         Abstract available


    Respirology

  19. IRUSEN EM, Meiring D, Koegelenberg CFN
    Asthma-COPD overlap and asthma progressing to COPD: Are we using the right diagnostic approaches and pathways?
    Respirology. 2024 May 7. doi: 10.1111/resp.14731.
    PubMed        

  20. DAVIS SR, Ampon RD, Poulos LM, Lee T, et al
    Prevalence and burden of difficult-to-treat and severe asthma in Australia: A national population survey.
    Respirology. 2024 May 6. doi: 10.1111/resp.14722.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.